Join the 'Corlanor' group to help and get support from people like you.
Posted 17 Oct 2016 by Drugs.com
MONDAY, Oct. 17, 2016 – Cholesterol-lowering statins can interact with other drugs prescribed for heart disease. But there are ways to navigate the problem, according to new recommendations from the American Heart Association. Statins are among the mostly widely prescribed drugs in the United States. Roughly one-quarter of Americans age 40 and up are on a statin, according to a 2014 study by the U.S. Centers for Disease Control and Prevention. The drugs are prescribed to people who either have atherosclerosis (clogged arteries) or are at risk of it, which means many statin users also take other cardiovascular drugs, the heart association says. The benefits of those drug combinations will generally outweigh the risks, said Barbara Wiggins, a clinical pharmacy specialist in cardiology at the Medical University of South Carolina. But doctors and patients should be aware of how the drugs ... Read more
Related support groups: Warfarin, Coumadin, Amlodipine, Lipitor, Simvastatin, Crestor, Diltiazem, Atorvastatin, Norvasc, Pravastatin, Verapamil, Amiodarone, Digoxin, Nifedipine, Cardizem, Zocor, Azor, Lovastatin, Exforge, Rosuvastatin
Posted 21 May 2016 by Drugs.com
FRIDAY, May 20, 2016 – An updated guideline adds two new types of drugs to the list of treatment options for heart failure. In people with the condition, the heart can't pump enough blood throughout the body. The two new treatments in the updated guidelines are an angiotensin receptor-neprilysin inhibitor (valsartan/sacubitril), sold as Entresto, and a sinoatrial node modulator (ivabradine), sold as Corlanor, according to the American College of Cardiology, the American Heart Association and the Heart Failure Society of America. Previously recommended drugs for these patients include angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers, beta blockers and diuretics. "Treatment options for patients with heart failure have expanded considerably. There is more hope than ever before for patients with heart failure," guideline update committee vice chair Dr. ... Read more